收藏切换
Progress on Chinese and western medicine for the treatment of corona virus disease 2019
收藏切换
Siriguleng1, Huanhuan LIU1, 2, Wurihan1, Xiaobin GUO1, Hongxin YANG1, *
World Clinical Drug | 2022, 43(7) : 939 - 945
Less
收藏切换
World Clinical Drug | 2022, 43(7): 939-945
• Review •
Progress on Chinese and western medicine for the treatment of corona virus disease 2019
Full
Siriguleng1, Huanhuan LIU1, 2, Wurihan1, Xiaobin GUO1, Hongxin YANG1, *
Affiliations
  • 1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China
  • 2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China
Published: 2022-07-10 doi: 10.13683/j.wph.2022.07.022
Outline
收藏切换

Corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are spreading globally on a large scale, threatening the safety of human life seriously, and the world needs effective drugs against COVID-19 urgently. Recently, four oral small molecule drugs have been successfully approved for market to treat patients with early mild COVID-19, they were 3C-like protease (3CLpro) inhibitor, RNA-dependent RNA polymerase (RdRp) inhibitor, monoclonal antibody, androgen receptor inhibitor. This paper briefly summarizes these four types of drugs and reviews their clinical therapeutic effects, characteristics and mechanism of action, to provide some references for the development and usage of drugs for the treatment of COVID-19.

severe acute respiratory syndrome coronavirus 2  /  corona virus disease 2019  /  oral small molecule drugs  /  traditional Chinese medicine  /  clinical trials  /  drug development
斯日古楞, 刘欢欢, 乌日汗, 郭小彬, 杨宏昕. 新型冠状病毒肺炎中西药物治疗的研究进展. 世界临床药物, 2022 , 43 (7) : 939 -945 . DOI: 10.13683/j.wph.2022.07.022
Siriguleng, Huanhuan LIU, Wurihan, Xiaobin GUO, Hongxin YANG. Progress on Chinese and western medicine for the treatment of corona virus disease 2019[J]. World Clinical Drug, 2022 , 43 (7) : 939 -945 . DOI: 10.13683/j.wph.2022.07.022
Year 2022 volume 43 Issue 7
13
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.07.022
  • Receive Date:2022-04-29
  • Online Date:2026-11-19
  • Published:2022-07-10
Article Data
Affiliations
History
  • Received:2022-04-29
Funding
Affiliations
    1.Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Municipality, China
    2.Department of Pharmacy, Baotou Medical College, Baotou 014060, Inner Mongolia Municipality, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.022
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT